{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:07:45Z","timestamp":1791410865944,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7642","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/nature21060","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T10:24:08Z","timestamp":1487067848000},"page":"445-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":385,"title":["Sterile protection against human malaria by chemoattenuated PfSPZ vaccine"],"prefix":"10.1038","volume":"542","author":[{"given":"Benjamin","family":"Mordm\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fczin","family":"Surat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heimo","family":"Lagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Lalremruata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Gmeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Ruben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Lamsfus","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana B.","family":"Mengue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamirat","family":"Gebru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Sulyok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KC","family":"Natasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Manoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooba","family":"Murshedkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Gunasekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham G.","family":"Eappen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil L.","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Seder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Richie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Kim Lee","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"BFnature21060_CR1","doi-asserted-by":"crossref","unstructured":"malERA Consultative Group on Vaccines. A research agenda for malaria eradication: vaccines. PLoS Med. 8, e1000398 (2011)","DOI":"10.1371\/journal.pmed.1000398"},{"key":"BFnature21060_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00000441-197309000-00002","volume":"266","author":"DF Clyde","year":"1973","unstructured":"Clyde, D. F., Most, H., McCarthy, V. C. & Vanderberg, J. P. Immunization of man against sporozite-induced falciparum malaria. Am. J. Med. Sci. 266, 169\u2013177 (1973)","journal-title":"Am. J. Med. Sci."},{"key":"BFnature21060_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0035-9203(74)90129-1","volume":"68","author":"KH Rieckmann","year":"1974","unstructured":"Rieckmann, K. H., Carson, P. E., Beaudoin, R. L., Cassells, J. S. & Sell, K. W. Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 68, 258\u2013259 (1974)","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"BFnature21060_CR4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1086\/339409","volume":"185","author":"SL Hoffman","year":"2002","unstructured":"Hoffman, S. L. et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185, 1155\u20131164 (2002)","journal-title":"J. Infect. Dis"},{"key":"BFnature21060_CR5","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1126\/science.1241800","volume":"341","author":"RA Seder","year":"2013","unstructured":"Seder, R. A. et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359\u20131365 (2013)","journal-title":"Science"},{"key":"BFnature21060_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm.4110","volume":"22","author":"AS Ishizuka","year":"2016","unstructured":"Ishizuka, A. S. et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat. Med. 22, 614\u2013623 (2016)","journal-title":"Nat. Med"},{"key":"BFnature21060_CR7","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/infdis\/jiu293","volume":"210","author":"EM Bijker","year":"2014","unstructured":"Bijker, E. M. et al. Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites. J. Infect. Dis. 210, 1605\u20131615 (2014)","journal-title":"J. Infect. Dis"},{"key":"BFnature21060_CR8","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1073\/pnas.1220360110","volume":"110","author":"EM Bijker","year":"2013","unstructured":"Bijker, E. M. et al. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc. Natl Acad. Sci. USA 110, 7862\u20137867 (2013)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature21060_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/NEJMoa0805832","volume":"361","author":"M Roestenberg","year":"2009","unstructured":"Roestenberg, M. et al. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 361, 468\u2013477 (2009)","journal-title":"N. Engl. J. Med"},{"key":"BFnature21060_CR10","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0140-6736(11)60360-7","volume":"377","author":"M Roestenberg","year":"2011","unstructured":"Roestenberg, M. et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377, 1770\u20131776 (2011)","journal-title":"Lancet"},{"key":"BFnature21060_CR11","doi-asserted-by":"publisher","first-page":"e112910","DOI":"10.1371\/journal.pone.0112910","volume":"9","author":"EM Bijker","year":"2014","unstructured":"Bijker, E. M. et al. Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial. PLoS One 9, e112910 (2014)","journal-title":"PLoS One"},{"key":"BFnature21060_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12936-015-0817-x","volume":"14","author":"GP G\u00f3mez-P\u00e9rez","year":"2015","unstructured":"G\u00f3mez-P\u00e9rez, G. P. et al. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naive volunteers: effect of injection volume and dose on infectivity rates. Malar. J. 14, 306 (2015)","journal-title":"Malar. J"},{"key":"BFnature21060_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12936-015-0628-0","volume":"14","author":"B Mordm\u00fcller","year":"2015","unstructured":"Mordm\u00fcller, B. et al. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar. J. 14, 117 (2015)","journal-title":"Malar. J"},{"key":"BFnature21060_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4269\/ajtmh.15-0621","volume":"94","author":"GJ Bastiaens","year":"2016","unstructured":"Bastiaens, G. J. et al. Safety, immunogenicity, and protective efficacy of intradermal immunization with aseptic, purified, cryopreserved Plasmodium falciparum sporozoites in volunteers under chloroquine prophylaxis: a randomized controlled trial. Am. J. Trop. Med. Hyg. 94, 663\u2013673 (2016)","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnature21060_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-4894(77)90054-6","volume":"42","author":"RL Beaudoin","year":"1977","unstructured":"Beaudoin, R. L., Strome, C. P. A., Mitchell, F. & Tubergen, T. A. Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp. Parasitol. 42, 1\u20135 (1977)","journal-title":"Exp. Parasitol"},{"key":"BFnature21060_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/329164a0","volume":"329","author":"C Guerin-Marchand","year":"1987","unstructured":"Guerin-Marchand, C. et al. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 329, 164\u2013167 (1987)","journal-title":"Nature"},{"key":"BFnature21060_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/mmi.12083","volume":"87","author":"Y Orito","year":"2013","unstructured":"Orito, Y. et al. Liver-specific protein 2: a Plasmodium protein exported to the hepatocyte cytoplasm and required for merozoite formation. Mol. Microbiol. 87, 66\u201379 (2013)","journal-title":"Mol. Microbiol"},{"key":"BFnature21060_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1073\/pnas.0710780104","volume":"105","author":"AS Tarun","year":"2008","unstructured":"Tarun, A. S. et al. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl Acad. Sci. USA 105, 305\u2013310 (2008)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature21060_CR19","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1016\/j.vaccine.2015.09.096","volume":"33","author":"TL Richie","year":"2015","unstructured":"Richie, T. L. et al. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine 33, 7452\u20137461 (2015)","journal-title":"Vaccine"},{"key":"BFnature21060_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.1211548","volume":"334","author":"JE Epstein","year":"2011","unstructured":"Epstein, J. E. et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 334, 475\u2013480 (2011)","journal-title":"Science"},{"key":"BFnature21060_CR21","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1128\/IAI.58.9.2834-2839.1990","volume":"58","author":"A Suhrbier","year":"1990","unstructured":"Suhrbier, A., Winger, L. A., Castellano, E. & Sinden, R. E. Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells. Infect. Immun. 58, 2834\u20132839 (1990)","journal-title":"Infect. Immun"},{"key":"BFnature21060_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1475-2875-13-136","volume":"13","author":"MC Behet","year":"2014","unstructured":"Behet, M. C. et al. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar. J. 13, 136 (2014)","journal-title":"Malar. J"},{"key":"BFnature21060_CR23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/330664a0","volume":"330","author":"L Schofield","year":"1987","unstructured":"Schofield, L. et al. \u03b3 Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664\u2013666 (1987)","journal-title":"Nature"},{"key":"BFnature21060_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1073\/pnas.85.2.573","volume":"85","author":"WR Weiss","year":"1988","unstructured":"Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H. & Good, M. F. CD8+ T cells (cytotoxic\/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl Acad. Sci. USA 85, 573\u2013576 (1988)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature21060_CR25","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.4049\/jimmunol.165.3.1453","volume":"165","author":"DL Doolan","year":"2000","unstructured":"Doolan, D. L. & Hoffman, S. L. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165, 1453\u20131462 (2000)","journal-title":"J. Immunol"},{"key":"BFnature21060_CR26","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.4049\/jimmunol.172.4.2487","volume":"172","author":"E Belnoue","year":"2004","unstructured":"Belnoue, E. et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 172, 2487\u20132495 (2004)","journal-title":"J. Immunol"},{"key":"BFnature21060_CR27","doi-asserted-by":"publisher","first-page":"e31247","DOI":"10.1371\/journal.pone.0031247","volume":"7","author":"WR Weiss","year":"2012","unstructured":"Weiss, W. R. & Jiang, C. G. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PLoS One 7, e31247 (2012)","journal-title":"PLoS One"},{"key":"BFnature21060_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","volume":"45","author":"D Fernandez-Ruiz","year":"2016","unstructured":"Fernandez-Ruiz, D. et al. Liver-resident memory CD8+ T cells form a front-line defense against malaria liver-stage infection. Immunity 45, 889\u2013902 (2016)","journal-title":"Immunity"},{"key":"BFnature21060_CR29","doi-asserted-by":"publisher","first-page":"e0124243","DOI":"10.1371\/journal.pone.0124243","volume":"10","author":"R Schats","year":"2015","unstructured":"Schats, R. et al. Heterologous protection against malaria after immunization with Plasmodium falciparum sporozoites. PLoS One 10, e0124243 (2015)","journal-title":"PLoS One"},{"key":"BFnature21060_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4269\/ajtmh.1993.49.166","volume":"49","author":"JE Egan","year":"1993","unstructured":"Egan, J. E. et al. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg. 49, 166\u2013173 (1993)","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnature21060_CR31","doi-asserted-by":"publisher","first-page":"e89154","DOI":"10.1172\/jci.insight.89154","volume":"2","author":"JE Epstein","year":"2017","unstructured":"Epstein, J. E. et al. Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. JCI Insight 2, e89154 (2017)","journal-title":"JCI Insight"},{"key":"BFnature21060_CR32","unstructured":"Lyke, K. et al. PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous malaria challenge. Proc. Natl Acad. Sci. USA (in the press)"},{"key":"BFnature21060_CR33","unstructured":"Sissoko, M. S. et al. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed Malian adults: a randomised, double-blind trial. Lancet Infect Dis. (in the press)"},{"key":"BFnature21060_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4269\/ajtmh.2012.12-0613","volume":"88","author":"M Roestenberg","year":"2013","unstructured":"Roestenberg, M. et al. Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg. 88, 5\u201313 (2013)","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnature21060_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fmicb.2015.00283","volume":"6","author":"T Sahu","year":"2015","unstructured":"Sahu, T. et al. Chloroquine neither eliminates liver stage parasites nor delays their development in a murine chemoprophylaxis vaccination model. Front. Microbiol. 6, 283 (2015)","journal-title":"Front. Microbiol"},{"key":"BFnature21060_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0035-9203(45)90038-1","volume":"38","author":"NH Fairley","year":"1945","unstructured":"Fairley, N. H. Chemotherapeutic suppression and prophylaxis in malaria. Trans. R. Soc. Trop. Med. Hyg. 38, 311\u2013365 (1945)","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"BFnature21060_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.4269\/ajtmh.2001.65.599","volume":"65","author":"T Planche","year":"2001","unstructured":"Planche, T. et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am. J. Trop. Med. Hyg. 65, 599\u2013602 (2001)","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"BFnature21060_CR38","doi-asserted-by":"publisher","first-page":"e71539","DOI":"10.1371\/journal.pone.0071539","volume":"8","author":"E Kamau","year":"2013","unstructured":"Kamau, E., Alemayehu, S., Feghali, K. C., Saunders, D. & Ockenhouse, C. F. Multiplex qPCR for detection and absolute quantification of malaria. PLoS One 8, e71539 (2013)","journal-title":"PLoS One"},{"key":"BFnature21060_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611\u2013622 (2009)","journal-title":"Clin. Chem"},{"key":"BFnature21060_CR40","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. (2015)"},{"key":"BFnature21060_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cyto.a.21015","volume":"79","author":"M Roederer","year":"2011","unstructured":"Roederer, M., Nozzi, J. L. & Nason, M. C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79, 167\u2013174 (2011)","journal-title":"Cytometry A"},{"key":"BFnature21060_CR42","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4269\/ajtmh.2006.74.708","volume":"74","author":"J Sattabongkot","year":"2006","unstructured":"Sattabongkot, J. et al. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am. J. Trop. Med. Hyg. 74, 708\u2013715 (2006)","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnature21060_CR43","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1038\/srep03549","volume":"3","author":"PL Felgner","year":"2013","unstructured":"Felgner, P. L. et al. Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci. Rep. 3, 3549 (2013)","journal-title":"Sci. Rep"},{"key":"BFnature21060_CR44","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1073\/pnas.0408782102","volume":"102","author":"DH Davies","year":"2005","unstructured":"Davies, D. H. et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl Acad. Sci. USA 102, 547\u2013552 (2005)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature21060_CR45","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/nprot.2006.268","volume":"1","author":"L Lamoreaux","year":"2006","unstructured":"Lamoreaux, L., Roederer, M. & Koup, R. Intracellular cytokine optimization and standard operating procedure. Nat. Protocols 1, 1507\u20131516 (2006)","journal-title":"Nat. Protocols"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature21060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature21060","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature21060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:59:01Z","timestamp":1684418341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature21060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":45,"journal-issue":{"issue":"7642","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFnature21060"],"URL":"https:\/\/doi.org\/10.1038\/nature21060","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"25 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.C., A.J.R., E.R.J., P.F.B., N.K, A.M., T.M., A.G., A.G.E., T.L., R.E.S, M.L., T.L.R., B.K.L.S. and S.L.H. are salaried employees of Sanaria Inc., the developer and owner of PfSPZ Challenge and the sponsor of the clinical trial. In addition, S.L.H. and B.K.L.S. have a financial interest in Sanaria Inc. J.J.C. is an Antigen Discovery Employee. P.L.F. owns stock and is a board member at Antigen Discovery, Inc. All other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}